Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease
about
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's diseaseMolecular interactions between apoE and ABCA1: impact on apoE lipidationApolipoprotein E and Alzheimer diseaseAnalysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia riskRelationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studiesThe MAP2/Tau family of microtubule-associated proteinsApolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factorsInhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cellsMorphological, Biochemical, and Genetic Support for an Apolipoprotein E Effect on Microtubular MetabolismaApolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice.ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry.Discovery of a brain promoter from the human transferrin gene and its utilization for development of transgenic mice that express human apolipoprotein E alleles.Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathologyGenetic dissection of Alzheimer disease, a heterogeneous disorder.Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses.Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases.Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicityApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotypeProtein aggregates and dementia: is there a common toxicity?The role of apolipoprotein E in Alzheimer's disease.Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms.Apolipoproteins in the brain: implications for neurological and psychiatric disorders.Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.The cellular distribution and Ser262 phosphorylation of tau protein are regulated by BDNF in vitro.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureFunctional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation.APOEε2 is associated with milder clinical and pathological Alzheimer disease.Specific regional transcription of apolipoprotein E in human brain neuronsExpression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.ApoE4-specific Misfolded Intermediate Identified by Molecular Dynamics Simulations.Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord.The many faces of tauCarboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic miceCSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimagingThe Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome.
P2860
Q22248091-A74E7278-0723-490C-8753-1705AD09047CQ24306797-73CEB70B-21D2-4FE2-B4A6-AEE189885397Q24563061-43E70C4C-5E28-4702-9E52-126F1C36FA7BQ24631195-811852C0-576F-40B4-86B0-19740C70C107Q24633831-C9E7A099-C430-459D-9530-75A3266EA8D7Q24805413-CC307A1D-4F65-422E-A548-80743CB1D0BFQ28576453-2DBE2594-FA76-4D8C-B791-0A0661015971Q28771380-2689055E-B284-4760-AC79-D8DF9ECB4984Q29041808-3ED9972D-A010-4582-8A27-DDAD3DD15624Q30497417-A085D919-6842-479C-B8B4-119E702EC1FCQ30539979-D551B1A8-7757-470C-919F-8C5FC67F3565Q30682249-68799748-10F1-4B13-921F-1A1A2F14CD3CQ33648946-EBBAFB2C-4684-4906-B9E2-C52C2279CC10Q33811028-AB0A2162-4025-4FC2-A52D-D3D5EF8D886BQ33909158-8A4EE63D-2010-4E32-AE9B-8578D4702849Q33919169-8395A230-9282-4D95-A021-121F1D261740Q33998681-46F559F4-6EE0-498E-AB33-8748162B7F34Q34034409-151860F9-18AD-444B-BE01-336E5CD9E9EAQ34045304-C66CC794-59E4-4E01-9AC6-2E9E797BC76DQ34122676-8095C473-BC54-402A-8D2E-CD7281A64DC0Q34210006-F7B1E269-5DEF-4118-B523-ADA284CEB19AQ34419653-2BD5E615-CC91-4A0A-B55D-9FE4777C769CQ34498308-EF304CB3-983F-42CE-86E6-BE4C5BBB76E7Q34603092-706BB27D-E7D3-4EFC-A26F-CB949709965AQ34621541-54C022DB-7ECB-4ACB-BA32-7179CAC8BA4EQ34628212-C1C81A4E-6C31-480B-96B8-5883FEF2AAF6Q34680878-638A21E8-A92C-4584-95BC-F1FB82131D59Q34709035-35E0C8F5-0E46-40FD-AB09-A0324A954078Q35117516-C7A5BE13-260F-4F2B-ABD6-E1CA72906C27Q35127516-EBECFA40-2FE9-4E09-946B-1582AA1A626BQ35565682-BD1C591C-2A52-42AA-BFAA-4B4650B6A21FQ35660968-B670FCA3-DD0E-4A27-A9D9-37107EBA018DQ35745315-7BE078DE-EF65-4FB8-8E61-1ABD63B04DAEQ35809803-DB878C05-21DC-4A6F-9D6D-D4A30E2C3FCAQ35823248-5E559D0B-E4E9-454C-BFE7-9AFC81F1C5DAQ35829610-1D82C65E-F579-406A-AEF3-EBC8EB7795B7Q35870359-893F62EF-0100-4C65-9C0C-E087BB8F593AQ35978742-72FFB169-C3C7-44D1-9330-E1093E0847DBQ36142582-B4CC14BC-62C3-41FB-A306-A91245AA8B4BQ36263047-092B22A1-0DFB-4580-A52C-51A72CB4AEE6
P2860
Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Isoform-specific interactions ...... ications for Alzheimer disease
@ast
Isoform-specific interactions ...... ications for Alzheimer disease
@en
Isoform-specific interactions ...... ications for Alzheimer disease
@en-gb
Isoform-specific interactions ...... ications for Alzheimer disease
@nl
type
label
Isoform-specific interactions ...... ications for Alzheimer disease
@ast
Isoform-specific interactions ...... ications for Alzheimer disease
@en
Isoform-specific interactions ...... ications for Alzheimer disease
@en-gb
Isoform-specific interactions ...... ications for Alzheimer disease
@nl
prefLabel
Isoform-specific interactions ...... ications for Alzheimer disease
@ast
Isoform-specific interactions ...... ications for Alzheimer disease
@en
Isoform-specific interactions ...... ications for Alzheimer disease
@en-gb
Isoform-specific interactions ...... ications for Alzheimer disease
@nl
P2093
P2860
P921
P356
P1476
Isoform-specific interactions ...... ications for Alzheimer disease
@en
P2093
A M Saunders
D Schmechel
K H Weisgraber
M Pericak-Vance
W J Strittmatter
P2860
P304
P356
10.1073/PNAS.91.23.11183
P407
P577
1994-11-08T00:00:00Z